United Capital Management Of Ks, Inc. Astrazeneca PLC Transaction History

United Capital Management Of Ks, Inc.

  • $404 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 01, 2019
SELL
$35.49 - $43.02 $188,309 - $228,264
-5,306 Closed
0 $0
Q4 2018

Jan 10, 2019
SELL
$36.86 - $41.49 $32,436 - $36,511
-880 Reduced 14.23%
5,306 $202,000
Q3 2018

Oct 09, 2018
BUY
$34.76 - $39.72 $215,025 - $245,707
6,186 New
6,186 $231,000

Others Institutions Holding AZN

# of Institutions
1,361
Shares Held
475M
Call Options Held
5.39M
Put Options Held
3.75M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track United Capital Management Of Ks, Inc. Portfolio

Follow United Capital Management Of Ks, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Management Of Ks, Inc., based on Form 13F filings with the SEC.

News

Stay updated on United Capital Management Of Ks, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email